Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events-Reference-Cited by-同舟云学术

Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events

Published:2017-07-25 Issue:6 Volume:10 Page:852-858
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Katalinić Nataša,Starčević Alma,Mavrinac Martina,Balen Sanja

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/10/6/852/22093032/sfx050.pdf

Reference39 articles.

1. Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation;World J Transplant,2014

2. HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation;Immunol Res,2006

3. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation;J Am Soc Nephrol,2010

4. HLA sensitisation: can it be prevented?;Pediatr Nephrol,2015

5. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes:,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of pretransplant suspected HLA antibody on the long-term outcome of the graft kidney: A retrospective cohort study;Transplant Immunology;2024-02

2. Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients;Transplantation Direct;2023-04-20

3. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases;Transplant Immunology;2022-12

4. The clinical utility and thresholds of virtual and Halifaster flow crossmatches in lung transplantation;HLA;2022-04-05

5. Positive Crossmatch Kidney Transplantation: State of the Art and Future Perspectives;Current Pharmaceutical Design;2020-08-31